520 related articles for article (PubMed ID: 30740946)
1. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis.
Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G
Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946
[TBL] [Abstract][Full Text] [Related]
2. Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients.
Galil SM; El-Shafey AM; Hagrass HA; Fawzy F; Sammak AE
Int J Rheum Dis; 2016 Apr; 19(4):377-84. PubMed ID: 25292349
[TBL] [Abstract][Full Text] [Related]
3. [The application of matrix metalloproteinase-3 and 7 joints ultrasonic score in assessment of disease activity in patients with rheumatoid arthritis].
Zhou L; Song J; Chen L; Xu HJ
Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):531-4. PubMed ID: 27373288
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage.
Skacelova M; Hermanova Z; Horak P; Ahmed K; Langova K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):296-302. PubMed ID: 28461705
[TBL] [Abstract][Full Text] [Related]
5. Serum matrix metalloproteinase 3 levels in comparison to C-reactive protein in periods with and without progression of radiological damage in patients with early rheumatoid arthritis.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
Clin Exp Rheumatol; 2003; 21(4):465-72. PubMed ID: 12942698
[TBL] [Abstract][Full Text] [Related]
6. Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.
Shinozaki M; Inoue E; Nakajima A; Hara M; Tomatsu T; Kamatani N; Yamanaka H
Mod Rheumatol; 2007; 17(5):403-8. PubMed ID: 17929133
[TBL] [Abstract][Full Text] [Related]
7. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
[TBL] [Abstract][Full Text] [Related]
8. Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression.
Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
J Rheumatol; 2000 Dec; 27(12):2761-8. PubMed ID: 11128661
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-cyclic citrullinated peptide antibodies with clinical and radiological disease severity in rheumatoid arthritis.
Gupta A; Kaushik R; Kaushik RM; Saini M; Kakkar R
Curr Rheumatol Rev; 2014; 10(2):136-43. PubMed ID: 25599684
[TBL] [Abstract][Full Text] [Related]
10. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis.
Cunnane G; Fitzgerald O; Beeton C; Cawston TE; Bresnihan B
Arthritis Rheum; 2001 Oct; 44(10):2263-74. PubMed ID: 11665967
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
12. Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.
Ma JD; Wei XN; Zheng DH; Mo YQ; Chen LF; Zhang X; Li JH; Dai L
Arthritis Res Ther; 2015 Oct; 17():289. PubMed ID: 26467222
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
[TBL] [Abstract][Full Text] [Related]
14. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(5):533-40. PubMed ID: 9779299
[TBL] [Abstract][Full Text] [Related]
15. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis.
Green MJ; Gough AK; Devlin J; Smith J; Astin P; Taylor D; Emery P
Rheumatology (Oxford); 2003 Jan; 42(1):83-8. PubMed ID: 12509618
[TBL] [Abstract][Full Text] [Related]
16. Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis.
Yamanaka H; Matsuda Y; Tanaka M; Sendo W; Nakajima H; Taniguchi A; Kamatani N
Arthritis Rheum; 2000 Apr; 43(4):852-8. PubMed ID: 10765930
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients.
Sulaiman FN; Wong KK; Ahmad WAW; Ghazali WSW
Medicine (Baltimore); 2019 Mar; 98(12):e14945. PubMed ID: 30896663
[TBL] [Abstract][Full Text] [Related]
20. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
